Infertility Devices Market is estimated to be valued at USD 11,969.3 Mn in 2025 and is expected to reach USD 21,462.3 Mn in 2032, exhibiting a compound annual growth rate (CAGR) of 8.7% from 2025 to 2032.
The Infertility Devices Market Size is boosting rapidly due to factors such as growing infertility rates, advances in technology, and growing demand for and awareness of reproductive treatments. Rising incidence of infertility, improvements in human reproductive technologies, and growing awareness and accessibility of fertility treatments globally are all contributing to the market for infertility devices. With major competitors seeking acquisitions and strategic alliances to broaden their product lines and geographic reach, the market is somewhat consolidated.
|
Event |
Description and Impact |
|
Surge in global infertility rates |
|
|
Government initiatives and funding for fertility treatments |
|
Uncover macros and micros vetted on 75+ parameters: Get instant access to report
In terms of product type, the equipment segment is expected to contribute largest share of 65.0% for the Infertility Devices market trends in 2025. Sperm analyzers are part of the equipment segment, which is a sizable and quickly expanding segment of the global market for infertility technologies.
In order to diagnose male infertility and guide assisted reproductive technologies (ART) like IVF and artificial insemination, sperm analyzer systems are specialized machines that evaluate a variety of sperm parameters, including count, motility, morphology, and viability.
In terms of procedures, the assisted reproductive technology segment is expected to contribute largest share of the Infertility Devices market trends in 2025. The IVF technology sector, in particular, has the most market share for ART because of its high success rates and wide range of applications in treating different reasons of infertility. Advancements include preimplantation genetic screening, embryo freezing, and time-lapse imaging have further solidified IVF's position as the industry leader.
In terms of gender, the female segment is expected to contribute largest share of the Infertility Devices market trends in 2025. Due to variables including obesity, poor lifestyles, and conditions like PCOS and PCOD, infertility is more common in women than in males. As a result, there is now more demand for infertility drugs and technology made especially for women.
In terms of end user, the fertility centers segment is expected to contribute largest share of the Infertility Devices market trends in 2025. The need for cutting-edge equipment and technologies in reproductive clinics is rising as a result of rising knowledge of fertility treatments and an increase in the number of couples seeking specialist care for infertility.
To learn more about this report, Download Free Sample
North America has historically been the dominant region as it drives major Infertility Devices Market Trends. North America is at the forefront of technological advancements in infertility devices. For instance, CooperSurgical, a U.S.-based company, launched the PristineTM, a next-generation in-vitro fertilization (IVF) workstation that enhances the efficiency and success rates of IVF procedures.
The increasing prevalence of infertility in the Asia Pacific region is driving the demand for infertility devices. According to a study by the Indian Society of Assisted Reproduction, infertility affects around 10-15% of the Indian population, which is approximately 27.5 million couples.
There is a growing awareness and acceptance of ART procedures such as in-vitro fertilization (IVF) and intrauterine insemination (IUI) in the Asia Pacific region. For example, in Japan, the number of ART cycles performed increased from 326,426 in 2010 to 447,790 in 2015, as reported by the Japan Society of Obstetrics and Gynecology.
The growing prevalence of infertility in Europe is a major driver for the market. A study published in the Human Reproduction Update journal in 2020 estimated that the prevalence of infertility in Europe ranges from 5.5% to 12.5% among women aged 20-44 years. Europe is known for its early adoption of advanced infertility treatment technologies.
Growth is fueled by the rising mean age of new mothers, improved diagnostic tools, and technological advancements in assisted reproductive technologies (ART), such as IVF and embryo cryopreservation. The presence of leading fertility clinics and device manufacturers, as well as continuous innovation in diagnostic and treatment devices, further strengthens the U.S. market’s dominance.
India is emerging as a significant player in the infertility devices market, propelled by rising infertility rates, greater awareness, and improved access to fertility treatments. Factors such as changing lifestyles, delayed parenthood, and increased prevalence of conditions like polycystic ovary syndrome (PCOS) contribute to the growing demand for infertility solutions.
China holds a dominant position in the Asia-Pacific infertility devices market, supported by a large population base, rising infertility rates, and strong government focus on healthcare modernization. The country has seen substantial investments in reproductive technology and the expansion of fertility clinics, particularly in urban centers.
| Report Coverage | Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 11,969.3 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 8.7% | 2032 Value Projection: | USD 21,462.3 Mn |
| Geographies covered: |
|
||
| Segments covered: |
|
||
| Companies covered: |
Carl Zeiss Meditec AG, Thermo Fisher Scientific Inc., Vitrolife AB, The Baker Company, Inc., The Cooper Companies, Inc., Fujifilm Irvine Scientific, IVFTECH APS, Kitazato Corporation, MedGyn Products, Inc., Rocket Medical plc, SOMATEX Medical Technologies GmbH, Cook Group Incorporated, Esco Micro Pte Ltd, Hamilton Thorne, Ltd, and Art Biotech Pvt. LTD |
||
| Growth Drivers: |
|
||
| Restraints & Challenges: |
|
||
Uncover macros and micros vetted on 75+ parameters: Get instant access to report
Increasing inorganic strategies such as acquisition by the key market players is expected to drive the infertility devices market growth over the forecast period. For instance, in December 2021, Cooper Companies Inc., a medical device company signed an agreement to acquire Generate Life Sciences, a leading provider of donor egg and sperm for fertility treatments, for fertility cryopreservation services and newborn stem cell storage (cord blood & cord tissue).
For instance, in February 2022, Cooper Companies Inc., a medical device company, announced that had signed a binding letter of intent to acquire Cook Medical’s Reproductive Health business, a manufacturer of minimally invasive medical devices focused on the fertility, obstetrics and gynecology markets.
The development of novel, minimally invasive infertility devices and the integration of digital health technologies, such as artificial intelligence in fertility diagnostics and monitoring, are creating new opportunities. These innovations improve treatment outcomes, patient comfort, and accessibility, making advanced infertility care more widely available.
Increasing infertility rates globally, driven by lifestyle changes, delayed parenthood, and environmental factors, are fueling demand for infertility treatments and devices. Greater awareness and acceptance of assisted reproductive technologies (ART) like IVF, IUI, and gamete cryopreservation are also expanding the market’s reach.
*Definition Infertility is a disease of the male or female reproductive system defined by the failure to achieve a pregnancy after 12 months or more of regular unprotected sexual intercourse. Infertility affects millions of people – and has an impact on their families and communities. Estimates suggest that approximately one in every six people of reproductive age worldwide experience infertility in their lifetime.
Share
Share
About Author
Manisha Vibhute is a consultant with over 5 years of experience in market research and consulting. With a strong understanding of market dynamics, Manisha assists clients in developing effective market access strategies. She helps medical device companies navigate pricing, reimbursement, and regulatory pathways to ensure successful product launches.
Missing comfort of reading report in your local language? Find your preferred language :
Transform your Strategy with Exclusive Trending Reports :
Frequently Asked Questions
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients
Schedule a meeting with report Author
